>>Signaling Pathways>> PROTAC>> E3 Ligase Ligand-Linker Conjugate>>Thalidomide-Piperazine-Piperidine hydrochloride

Thalidomide-Piperazine-Piperidine hydrochloride

Catalog No.GC64640

탈리도마이드-피페라진-피페리딘 염산염은 합성된 E3 리가제 리간드-링커 접합체입니다. 탈리도마이드-피페라진-피페리딘 염산염은 탈리도마이드 기반 세레블론 리간드와 PROTAC 기술에 사용되는 링커를 통합합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Thalidomide-Piperazine-Piperidine hydrochloride Chemical Structure

Cas No.: 2599846-44-1

Size 가격 재고 수량
5 mg
US$315.00
재고 있음
10 mg
US$522.00
재고 있음
25 mg
US$990.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Thalidomide-Piperazine-Piperidine hydrochloride is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-Piperazine-Piperidine hydrochloride incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

[1]. Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine. Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11.

리뷰

Review for Thalidomide-Piperazine-Piperidine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Thalidomide-Piperazine-Piperidine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.